You are here

Generic drug makers seek new ways to do business


SIXTEEN years ago, Glenn Saldanha took over his father's business making copycat versions of novel medicines and added a side bet of his own: Instead of just imitating old drugs, his family firm would try to innovate completely new ones too.

Investors complained, competitors...

Market voices on: